Atlas Trials

Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT02467452 · COMPLETED

Trial details

NCT number
NCT02467452
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2015-05-01
Primary completion
2017-01-01
Enrollment
1479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.